BioSpace News Archive

Lone Star Bio

Money on the Move: November 10 – 16

Investors are falling in with these biotech companies, dropping dollars to fuel their work for the latest advancement in life sciences.

November 17, 2021
·
3 min read
·
Kate Goodwin
Business

Warren Buffet Scales Back Big Biopharma Investments

This week, Berkshire announced that it has scaled back those investments, and completely eliminated its stake in Merck.

November 17, 2021
·
2 min read
·
Heather McKenzie
Policy

Biogen’s Aduhelm Faces Another Setback as EU Votes No

The Committee for Medicinal Products for Human Use of the European Medicines Agency issued a negative trend vote on the company’s Marketing Authorization Application for Aduhelm.

November 17, 2021
·
3 min read
·
Mark Terry
Policy

Three Pharma Companies Seek to Address FDA Rejections

Iterum Therapeutics will head back into the clinic to meet regulatory requirements to refile a New Drug Application for oral sulopenem.

November 17, 2021
·
3 min read
·
Alex Keown
Deals

Valo Health, Khosla Ventures Terminate Merger Plans At Last Minute

Under the terms of their merger agreement, the deal can be terminated at any time. Know what happened between Valo Health & Khosla Ventures before the merger.

November 17, 2021
·
2 min read
·
Vanessa Doctor, RN
Business

Global Roundup: Galapagos NV Wins European Approval for Ulcerative Colitis Therapy

Biopharma and life sciences companies from across the globe provide updates. Belgium-based Galapagos NV won European approval for Jyseleca for the treatment of adult patients with moderately to severely active ulcerative colitis (UC).

November 17, 2021
·
6 min read
·
Alex Keown
Combatting Seasonal Affective Disorder in the Office

Seasonal Affective Disorder more than winter blues, and there are steps to take to prevent it or combat the sadness and lack of energy. Know more about it here.

November 17, 2021
·
4 min read
·
Karen Walpole
Policy

SEC Launches Investigation into Manipulated Alzheimer’s Study Data Claims

The U.S. Securities and Exchange Commission has launched an investigation into Texas-based Cassava Sciences.

November 17, 2021
·
3 min read
·
Mark Terry
Business

Longtime Pfizer CFO Frank D’Amelio Plans Exit

Pfizer is initiating an external search for a new CFO with Frank D’Amelio agreeing to remain with the company through the transition.

November 17, 2021
·
3 min read
·
Alex Keown
Policy

US Spends $1 Billion on GSK-Vir Antibody; Pfizer Requests Paxlovid Approval

While COVID-19 appears to be surging again in the U.S. and Europe, the government is spending billions to acquire antibody and antiviral therapies and edging toward vaccination boosters.

November 17, 2021
·
4 min read
·
Mark Terry